AKBA Akebia Therapeutics, Inc.
Healthcare$1.02+0.00%ClosedMarket Cap: $273.6M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$4.00
Target (Median)
$4.00
Target Range
$4.00 - $4.00
Upside from current price: 292.2%
Rating Distribution
1 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-07 | BTIG | maintain | Buy | Buy |
| 2026-02-25 | BTIG | maintain | Buy | Buy |
| 2026-02-06 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-06 | Piper Sandler | maintain | Overweight | Overweight |
| 2025-12-02 | BTIG | maintain | Buy | Buy |
| 2025-12-02 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-30 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-29 | BTIG | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.23 | $159.7M | 3 |
| Sun Dec 31 | $-0.10 | $202.4M | 4 |
| Mon Dec 31 | $-0.05 | $221.5M | 2 |
| Tue Dec 31 | $0.01 | $263.0M | 2 |